O'Shaughnessy Asset Management, LLC Iveric Bio, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$5.65 - $7.66 $260,905 - $353,723	-46,178 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$4.01 - $6.29 $51,328 - $80,512	-12,800 Reduced 21.7%	46,178 $261,000
Q2 2020 Aug 13, 2020	SELL	$3.06 - $6.6 $30,869 - $66,580	-10,088 Reduced 14.61%	58,978 $301,000
Q1 2020 May 13, 2020	BUY	$2.83 - $8.44 $195,456 - $582,917	69,066 New	69,066 $239,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.